Cargando…

Drug Repositioning in Friedreich Ataxia

Friedreich ataxia is a rare neurodegenerative disorder caused by insufficient levels of the essential mitochondrial protein frataxin. It is a severely debilitating disease that significantly impacts the quality of life of affected patients and reduces their life expectancy, however, an adequate cure...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rufini, Alessandra, Malisan, Florence, Condò, Ivano, Testi, Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863941/ https://www.ncbi.nlm.nih.gov/pubmed/35221903 http://dx.doi.org/10.3389/fnins.2022.814445

Ejemplares similares

Interferon Gamma Enhances Cytoprotective Pathways via Nrf2 and MnSOD Induction in Friedreich’s Ataxia Cells
por: Luffarelli, Riccardo, et al.
Publicado: (2023)

E3 Ligase RNF126 Directly Ubiquitinates Frataxin, Promoting Its Degradation: Identification of a Potential Therapeutic Target for Friedreich Ataxia
por: Benini, Monica, et al.
Publicado: (2017)

Sensitivity of Neuroimaging Indicators in Monitoring the Effects of Interferon Gamma Treatment in Friedreich’s Ataxia
por: Vavla, Marinela, et al.
Publicado: (2020)

Highly specific ubiquitin-competing molecules effectively promote frataxin accumulation and partially rescue the aconitase defect in Friedreich ataxia cells
por: Rufini, Alessandra, et al.
Publicado: (2015)

Interferon gamma upregulates frataxin and corrects the functional deficits in a Friedreich ataxia model
por: Tomassini, Barbara, et al.
Publicado: (2012)

Acetylation Suppresses the Proapoptotic Activity of GD3 Ganglioside
por: Malisan, Florence, et al.
Publicado: (2002)

SINEUP non-coding RNAs rescue defective frataxin expression and activity in a cellular model of Friedreich's Ataxia
por: Bon, Carlotta, et al.
Publicado: (2019)

Plasma Markers of Neurodegeneration Are Raised in Friedreich’s Ataxia
por: Zeitlberger, Anna M., et al.
Publicado: (2018)

Erythropoietin and Friedreich Ataxia: Time for a Reappraisal?
por: Boesch, Sylvia, et al.
Publicado: (2019)

Friedreich's Ataxia
por: Anderson, J. Wallace
Publicado: (1893)

Cerebellar Pathology in an Inducible Mouse Model of Friedreich Ataxia
por: Mercado-Ayón, Elizabeth, et al.
Publicado: (2022)

Calcium Deregulation: Novel Insights to Understand Friedreich’s Ataxia Pathophysiology
por: Abeti, Rosella, et al.
Publicado: (2018)

Epigenetic Heterogeneity in Friedreich Ataxia Underlies Variable FXN Reactivation
por: Rodden, Layne N., et al.
Publicado: (2021)

Neuroinflammation in Friedreich’s Ataxia
por: Apolloni, Savina, et al.
Publicado: (2022)

The Pathology of Friedreich's Ataxia
por: Rainy, Harry
Publicado: (1905)

Cerebrospinal Fluid Proteomics in Friedreich Ataxia Reveals Markers of Neurodegeneration and Neuroinflammation
por: Imbault, Virginie, et al.
Publicado: (2022)

Autonomic function testing in Friedreich’s ataxia
por: Indelicato, Elisabetta, et al.
Publicado: (2018)

Bone Mineral Density and Current Bone Health Screening Practices in Friedreich’s Ataxia
por: Dunn, Julia, et al.
Publicado: (2022)

Large Interruptions of GAA Repeat Expansion Mutations in Friedreich Ataxia Are Very Rare
por: Al-Mahdawi, Sahar, et al.
Publicado: (2018)

Skeletal muscle proteome analysis underpins multifaceted mitochondrial dysfunction in Friedreich’s ataxia
por: Indelicato, Elisabetta, et al.
Publicado: (2023)

Respiratory Function in Friedreich’s Ataxia
por: Vinante, Elena, et al.
Publicado: (2022)

Is Friedreich ataxia an epigenetic disorder?
por: Kumari, Daman, et al.
Publicado: (2012)

The Pathogenesis of Cardiomyopathy in Friedreich Ataxia
por: Koeppen, Arnulf H., et al.
Publicado: (2015)

Depressive symptoms in Friedreich ataxia
por: Nieto, Antonieta, et al.
Publicado: (2018)

Heart disease in Friedreich’s ataxia
por: Hanson, Emily, et al.
Publicado: (2019)

Two Cases of Friedreich’s Ataxia
por: Stephenson, F. H.
Publicado: (1897)

Mechanism of Action of 2-Aminobenzamide HDAC Inhibitors in Reversing Gene Silencing in Friedreich’s Ataxia
por: Soragni, Elisabetta, et al.
Publicado: (2015)

Friedreich ataxia in a family from Mali, West Africa/Friedreich ataxia in a Malian family
por: Cissé, Cheick A. K., et al.
Publicado: (2021)

Perspectives on current models of Friedreich’s ataxia
por: Kelekçi, Simge, et al.
Publicado: (2022)

Prediction of the disease course in Friedreich ataxia
por: Hohenfeld, Christian, et al.
Publicado: (2022)

Anaesthesia for a patient with Friedreich's ataxia
por: Ganesan, Ilango
Publicado: (2011)

Hepatic mitochondrial dysfunction in Friedreich Ataxia
por: Stüwe, Sven H, et al.
Publicado: (2011)

Epigenetic-based therapies for Friedreich ataxia
por: Sandi, Chiranjeevi, et al.
Publicado: (2014)

Identification of telomere dysfunction in Friedreich ataxia
por: Anjomani Virmouni, Sara, et al.
Publicado: (2015)

Otoneurological Abnormalities in Patients with Friedreich's Ataxia
por: Zeigelboim, Bianca Simone, et al.
Publicado: (2016)

The role of oxidative stress in Friedreich's ataxia
por: Lupoli, Federica, et al.
Publicado: (2017)

Two Cases of Friedreich's Ataxia in Adolescents
por: Fergus, John
Publicado: (1917)

Drosophila melanogaster Models of Friedreich's Ataxia
por: Calap-Quintana, P., et al.
Publicado: (2018)

An Overview of the Ferroptosis Hallmarks in Friedreich’s Ataxia
por: Turchi, Riccardo, et al.
Publicado: (2020)

Predictors of loss of ambulation in Friedreich's ataxia
por: Rummey, Christian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_632h1tih9olpmov873od90nrkc